The impact of immune restoration has been clearly demonstrated in cohort studies and randomized clinical trials that have shown decreased mortality and morbidity, including AIDS defining clinical events and tuberculosis, with initiation of ART at higher CD4 counts [1], [4]–[12]. This evidence concerns the gene CD4 and tuberculosis.